Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRA is a concentrated traditional Chinese herbal extract granule formulation developed by Changhua Christian Hospital. It is designed as a non-antibiotic prophylactic intervention to prevent symptomatic urinary tract infections (UTIs) and reduce associated hospitalizations, particularly in high-risk elderly populations such as nursing home residents. The formulation consists of standardized herbal extracts intended to provide an alternative to conventional antimicrobial therapy, thereby addressing concerns regarding increasing antimicrobial resistance in long-term care settings. In clinical evaluations, it is administered orally as granules dissolved in water.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TRA.